26.44 USD
▲+0.25+4.26%
盘后 25.66 +1.18%
2026-08-03
市值
$509.00M
市盈率
—
EPS
-0.47
股息率
—
52 周区间
17.98 – 39.71
成交量
90.95K
Beta
1.08
目标价
50.00
52W 低 17.9852W 高 39.71
价格走势
公司简介
Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection. The company also develops ABI-4334, an orally bioavailable next g...